2000
DOI: 10.1016/s0014-5793(00)01751-8
|View full text |Cite
|
Sign up to set email alerts
|

The HIV‐1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression

Abstract: HIV-1 external envelope glycoprotein gp120 inhibits adenosine deaminase (ADA) binding to its cell surface receptor in lymphocytes, CD26, by a mechanism that does not require the gp120^CD4 interaction. To further characterize this mechanism, we studied ADA binding to murine clones stably expressing human CD26 and/or human CD4, and transiently expressing human CXCR4. In this heterologous model, we show that both recombinant gp120 and viral particles from the X4 HIV-1 isolate IIIB inhibited the binding of ADA to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
27
0

Year Published

2001
2001
2021
2021

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 33 publications
(28 citation statements)
references
References 41 publications
1
27
0
Order By: Relevance
“…To determine whether the costimulatory effect of ADA is due to the association between ADA and CD26 on the T cell surface in the immunological synapse, cocultures were performed in conditions at which the ADA-CD26 interaction was interfered by using the anti-CD26 mAb Ta5.9, which is directed against the ADA binding domain of CD26 (35,36). When T cells were preincubated with Ta5.9 before the coculture with ADA-treated DC, the costimulatory effect of ADA in T cell activation was abrogated (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…To determine whether the costimulatory effect of ADA is due to the association between ADA and CD26 on the T cell surface in the immunological synapse, cocultures were performed in conditions at which the ADA-CD26 interaction was interfered by using the anti-CD26 mAb Ta5.9, which is directed against the ADA binding domain of CD26 (35,36). When T cells were preincubated with Ta5.9 before the coculture with ADA-treated DC, the costimulatory effect of ADA in T cell activation was abrogated (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…17 By acting as a bridge between A 2B adenosine receptors on dendritic cells (DCs) surface and CD26 on T-cells surface, ADA acts as a costimulatory molecule in cocultures of SEA-presenting DCs and autologous T cells, not only enhancing T-cell proliferation, Th-1/pro-inflammatory cytokine secretion, 17 and naïve T-CD4 + cell activation, memory, and FOXP3 + generation, 18 but also increasing DCs immunogenicity in both healthy and HIVinfected subjects. 63 Although HIV gp120 envelope protein disrupts ADA-CD26 interaction, 64 possibly contributing to the HIV-promoted immunodeficiency, 19 ADA is still able to enhance autologous T-cell proliferation against inactivated-HIV presentation by DC in individuals under cART (Fig. 3), 16 suggesting a beneficial role for ADA on improving HIV-specific T-cell responses in those individuals.…”
Section: Adjuvants To Favor or Impair Antigen Presentationmentioning
confidence: 99%
“…The HIV envelope is believed to be a major player in the HIV-mediated killing of uninfected CD4 T cells. Envelope-induced apoptosis occurs as a result of an infected cell's interaction with an uninfected cell CD4 receptor (1,23,40) and/or the CXCR4/CCR5 coreceptor (11,13,14,45). Infected macrophages can also contribute to the depletion of uninfected T lymphocytes by inducing apoptosis in both CD4 ϩ and CD8 ϩ cells (6,8).…”
Section: Discussionmentioning
confidence: 99%